Longitudinal study of children with perinatal brain damage in whom early neurohabilitation was applied: Preliminary report

•It is a longitudinal study of perinatal brain damaged children.•Katona’s neurohabilitation procedure was used as treatment.•89% of preterm ≤34 weeks treated had normal neurodevelopment.•Only 20% of non-treated preterm ≤34 weeks had normal neurodevelopment.•Application of neurohabilitation to perina...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 2016-01, Vol.611, p.59-67
Hauptverfasser: Harmony, Thalía, Barrera-Reséndiz, Jesús, Juárez-Colín, María Elena, Carrillo-Prado, Cristina, del Consuelo Pedraza-Aguilar, M., Asprón Ramírez, Aurora, Hinojosa-Rodríguez, Manuel, Fernández, Thalía, Ricardo-Garcell, Josefina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 67
container_issue
container_start_page 59
container_title Neuroscience letters
container_volume 611
creator Harmony, Thalía
Barrera-Reséndiz, Jesús
Juárez-Colín, María Elena
Carrillo-Prado, Cristina
del Consuelo Pedraza-Aguilar, M.
Asprón Ramírez, Aurora
Hinojosa-Rodríguez, Manuel
Fernández, Thalía
Ricardo-Garcell, Josefina
description •It is a longitudinal study of perinatal brain damaged children.•Katona’s neurohabilitation procedure was used as treatment.•89% of preterm ≤34 weeks treated had normal neurodevelopment.•Only 20% of non-treated preterm ≤34 weeks had normal neurodevelopment.•Application of neurohabilitation to perinatal brain damaged infants is recommended. The neurohabilitation treatment has been shown to be a successful method for decreasing the sequelae of perinatal brain damage (PBD) in Hungarian population. The goal of this pilot trial was to introduce this procedure by describing the results of its application in infants with PBD as demonstrated by clinical, developmental and MRI studies. As this procedure has proved to be useful, according the declaration of Helsinki, no control clinical trial was permitted. Infants younger than 2 months of corrected age (CA) with prenatal and/or perinatal risk factors for brain damage. Two groups were considered. One group was treated using the “neurohabilitation” method (n=20), and the other was not treated (n=13) because treatment was voluntarily discontinued after the initial evaluation. Evaluations were carried out prior to 2 months of CA and at 6–8 years of age. All children showed abnormal clinical and MRI characteristics in the first study. The treated group had a higher percentage (90%) of children with normal outcome than did the non-treated group (38%; OR=2.37, CI 95%=1.2–4.7; p
doi_str_mv 10.1016/j.neulet.2015.11.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1753011724</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304394015302500</els_id><sourcerecordid>1753011724</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-3b05e13f43289ffd76eadb802f7880c9b862d6412783f162669a20bab88f2fe33</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi1ERZfCP0DIRy4JHjsfDgckVLWAtBI9wNly4nHXKycOtkO1_HpcbeHIySPNMzOvH0LeAKuBQff-WC-4ecw1Z9DWADUD8YzsQPa86oeePyc7JlhTiaFhl-RlSkfGWAtt84Jc8q4dJOOwI7_3Ybl3eTNu0Z6mUpxosHQ6OG8iLvTB5QNdMZZ2LsAYtVuo0bO-R1qqh0OYKeroT7SkieGgR-dd1tmF0tSJ6nX1Ds0HehfRu7msiScacQ0xvyIXVvuEr5_eK_Lj9ub79Zdq_-3z1-tP-2oSHc-VGFmLIGwjuBysNX2H2owlve2lZNMwyo6brgHeS2Gh4103aM5GPUppuUUhrsi78941hp8bpqxmlyb0Xi8YtqSgbwUD6HlT0OaMTjGkFNGqNbq5RFbA1KN1dVRn6-rRugJQxXoZe_t0YRtnNP-G_mouwMczgOWfvxxGlSaHy4TGRZyyMsH9_8Ifaz-Xgg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753011724</pqid></control><display><type>article</type><title>Longitudinal study of children with perinatal brain damage in whom early neurohabilitation was applied: Preliminary report</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Harmony, Thalía ; Barrera-Reséndiz, Jesús ; Juárez-Colín, María Elena ; Carrillo-Prado, Cristina ; del Consuelo Pedraza-Aguilar, M. ; Asprón Ramírez, Aurora ; Hinojosa-Rodríguez, Manuel ; Fernández, Thalía ; Ricardo-Garcell, Josefina</creator><creatorcontrib>Harmony, Thalía ; Barrera-Reséndiz, Jesús ; Juárez-Colín, María Elena ; Carrillo-Prado, Cristina ; del Consuelo Pedraza-Aguilar, M. ; Asprón Ramírez, Aurora ; Hinojosa-Rodríguez, Manuel ; Fernández, Thalía ; Ricardo-Garcell, Josefina</creatorcontrib><description>•It is a longitudinal study of perinatal brain damaged children.•Katona’s neurohabilitation procedure was used as treatment.•89% of preterm ≤34 weeks treated had normal neurodevelopment.•Only 20% of non-treated preterm ≤34 weeks had normal neurodevelopment.•Application of neurohabilitation to perinatal brain damaged infants is recommended. The neurohabilitation treatment has been shown to be a successful method for decreasing the sequelae of perinatal brain damage (PBD) in Hungarian population. The goal of this pilot trial was to introduce this procedure by describing the results of its application in infants with PBD as demonstrated by clinical, developmental and MRI studies. As this procedure has proved to be useful, according the declaration of Helsinki, no control clinical trial was permitted. Infants younger than 2 months of corrected age (CA) with prenatal and/or perinatal risk factors for brain damage. Two groups were considered. One group was treated using the “neurohabilitation” method (n=20), and the other was not treated (n=13) because treatment was voluntarily discontinued after the initial evaluation. Evaluations were carried out prior to 2 months of CA and at 6–8 years of age. All children showed abnormal clinical and MRI characteristics in the first study. The treated group had a higher percentage (90%) of children with normal outcome than did the non-treated group (38%; OR=2.37, CI 95%=1.2–4.7; p&lt;0.005). In this latter group, only one out of five (20%) children born at or before 34 weeks of gestational age had a normal outcome. In contrast, eight out of nine treated preterm infants had normal outcomes (8/9=89%, OR=4.45, CI 95%=0.7–26; p=0.017). This pilot trial confirms previous studies suggesting that Neurohabilitation decreases the neurological and cognitive sequelae of preterm and at-term infants with PBD.</description><identifier>ISSN: 0304-3940</identifier><identifier>EISSN: 1872-7972</identifier><identifier>DOI: 10.1016/j.neulet.2015.11.013</identifier><identifier>PMID: 26598021</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Brain - growth &amp; development ; Brain - pathology ; Brain Diseases - diagnosis ; Brain Diseases - pathology ; Brain Diseases - physiopathology ; Brain Diseases - rehabilitation ; Child ; Child, Preschool ; Female ; Humans ; Hypoxic ischemic encephalopathy ; Infant ; Locomotion ; Longitudinal Studies ; Magnetic Resonance Imaging ; Male ; MRI ; Neurohabilitation ; Perinatal brain damage ; Pilot Projects ; Prenatal risk factors ; Preterm encephalopathy ; Walking</subject><ispartof>Neuroscience letters, 2016-01, Vol.611, p.59-67</ispartof><rights>2015 Elsevier Ireland Ltd</rights><rights>Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-3b05e13f43289ffd76eadb802f7880c9b862d6412783f162669a20bab88f2fe33</citedby><cites>FETCH-LOGICAL-c362t-3b05e13f43289ffd76eadb802f7880c9b862d6412783f162669a20bab88f2fe33</cites><orcidid>0000-0002-6336-4173</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neulet.2015.11.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26598021$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harmony, Thalía</creatorcontrib><creatorcontrib>Barrera-Reséndiz, Jesús</creatorcontrib><creatorcontrib>Juárez-Colín, María Elena</creatorcontrib><creatorcontrib>Carrillo-Prado, Cristina</creatorcontrib><creatorcontrib>del Consuelo Pedraza-Aguilar, M.</creatorcontrib><creatorcontrib>Asprón Ramírez, Aurora</creatorcontrib><creatorcontrib>Hinojosa-Rodríguez, Manuel</creatorcontrib><creatorcontrib>Fernández, Thalía</creatorcontrib><creatorcontrib>Ricardo-Garcell, Josefina</creatorcontrib><title>Longitudinal study of children with perinatal brain damage in whom early neurohabilitation was applied: Preliminary report</title><title>Neuroscience letters</title><addtitle>Neurosci Lett</addtitle><description>•It is a longitudinal study of perinatal brain damaged children.•Katona’s neurohabilitation procedure was used as treatment.•89% of preterm ≤34 weeks treated had normal neurodevelopment.•Only 20% of non-treated preterm ≤34 weeks had normal neurodevelopment.•Application of neurohabilitation to perinatal brain damaged infants is recommended. The neurohabilitation treatment has been shown to be a successful method for decreasing the sequelae of perinatal brain damage (PBD) in Hungarian population. The goal of this pilot trial was to introduce this procedure by describing the results of its application in infants with PBD as demonstrated by clinical, developmental and MRI studies. As this procedure has proved to be useful, according the declaration of Helsinki, no control clinical trial was permitted. Infants younger than 2 months of corrected age (CA) with prenatal and/or perinatal risk factors for brain damage. Two groups were considered. One group was treated using the “neurohabilitation” method (n=20), and the other was not treated (n=13) because treatment was voluntarily discontinued after the initial evaluation. Evaluations were carried out prior to 2 months of CA and at 6–8 years of age. All children showed abnormal clinical and MRI characteristics in the first study. The treated group had a higher percentage (90%) of children with normal outcome than did the non-treated group (38%; OR=2.37, CI 95%=1.2–4.7; p&lt;0.005). In this latter group, only one out of five (20%) children born at or before 34 weeks of gestational age had a normal outcome. In contrast, eight out of nine treated preterm infants had normal outcomes (8/9=89%, OR=4.45, CI 95%=0.7–26; p=0.017). This pilot trial confirms previous studies suggesting that Neurohabilitation decreases the neurological and cognitive sequelae of preterm and at-term infants with PBD.</description><subject>Brain - growth &amp; development</subject><subject>Brain - pathology</subject><subject>Brain Diseases - diagnosis</subject><subject>Brain Diseases - pathology</subject><subject>Brain Diseases - physiopathology</subject><subject>Brain Diseases - rehabilitation</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Humans</subject><subject>Hypoxic ischemic encephalopathy</subject><subject>Infant</subject><subject>Locomotion</subject><subject>Longitudinal Studies</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>MRI</subject><subject>Neurohabilitation</subject><subject>Perinatal brain damage</subject><subject>Pilot Projects</subject><subject>Prenatal risk factors</subject><subject>Preterm encephalopathy</subject><subject>Walking</subject><issn>0304-3940</issn><issn>1872-7972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi1ERZfCP0DIRy4JHjsfDgckVLWAtBI9wNly4nHXKycOtkO1_HpcbeHIySPNMzOvH0LeAKuBQff-WC-4ecw1Z9DWADUD8YzsQPa86oeePyc7JlhTiaFhl-RlSkfGWAtt84Jc8q4dJOOwI7_3Ybl3eTNu0Z6mUpxosHQ6OG8iLvTB5QNdMZZ2LsAYtVuo0bO-R1qqh0OYKeroT7SkieGgR-dd1tmF0tSJ6nX1Ds0HehfRu7msiScacQ0xvyIXVvuEr5_eK_Lj9ub79Zdq_-3z1-tP-2oSHc-VGFmLIGwjuBysNX2H2owlve2lZNMwyo6brgHeS2Gh4103aM5GPUppuUUhrsi78941hp8bpqxmlyb0Xi8YtqSgbwUD6HlT0OaMTjGkFNGqNbq5RFbA1KN1dVRn6-rRugJQxXoZe_t0YRtnNP-G_mouwMczgOWfvxxGlSaHy4TGRZyyMsH9_8Ifaz-Xgg</recordid><startdate>20160112</startdate><enddate>20160112</enddate><creator>Harmony, Thalía</creator><creator>Barrera-Reséndiz, Jesús</creator><creator>Juárez-Colín, María Elena</creator><creator>Carrillo-Prado, Cristina</creator><creator>del Consuelo Pedraza-Aguilar, M.</creator><creator>Asprón Ramírez, Aurora</creator><creator>Hinojosa-Rodríguez, Manuel</creator><creator>Fernández, Thalía</creator><creator>Ricardo-Garcell, Josefina</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6336-4173</orcidid></search><sort><creationdate>20160112</creationdate><title>Longitudinal study of children with perinatal brain damage in whom early neurohabilitation was applied: Preliminary report</title><author>Harmony, Thalía ; Barrera-Reséndiz, Jesús ; Juárez-Colín, María Elena ; Carrillo-Prado, Cristina ; del Consuelo Pedraza-Aguilar, M. ; Asprón Ramírez, Aurora ; Hinojosa-Rodríguez, Manuel ; Fernández, Thalía ; Ricardo-Garcell, Josefina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-3b05e13f43289ffd76eadb802f7880c9b862d6412783f162669a20bab88f2fe33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Brain - growth &amp; development</topic><topic>Brain - pathology</topic><topic>Brain Diseases - diagnosis</topic><topic>Brain Diseases - pathology</topic><topic>Brain Diseases - physiopathology</topic><topic>Brain Diseases - rehabilitation</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Humans</topic><topic>Hypoxic ischemic encephalopathy</topic><topic>Infant</topic><topic>Locomotion</topic><topic>Longitudinal Studies</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>MRI</topic><topic>Neurohabilitation</topic><topic>Perinatal brain damage</topic><topic>Pilot Projects</topic><topic>Prenatal risk factors</topic><topic>Preterm encephalopathy</topic><topic>Walking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harmony, Thalía</creatorcontrib><creatorcontrib>Barrera-Reséndiz, Jesús</creatorcontrib><creatorcontrib>Juárez-Colín, María Elena</creatorcontrib><creatorcontrib>Carrillo-Prado, Cristina</creatorcontrib><creatorcontrib>del Consuelo Pedraza-Aguilar, M.</creatorcontrib><creatorcontrib>Asprón Ramírez, Aurora</creatorcontrib><creatorcontrib>Hinojosa-Rodríguez, Manuel</creatorcontrib><creatorcontrib>Fernández, Thalía</creatorcontrib><creatorcontrib>Ricardo-Garcell, Josefina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harmony, Thalía</au><au>Barrera-Reséndiz, Jesús</au><au>Juárez-Colín, María Elena</au><au>Carrillo-Prado, Cristina</au><au>del Consuelo Pedraza-Aguilar, M.</au><au>Asprón Ramírez, Aurora</au><au>Hinojosa-Rodríguez, Manuel</au><au>Fernández, Thalía</au><au>Ricardo-Garcell, Josefina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Longitudinal study of children with perinatal brain damage in whom early neurohabilitation was applied: Preliminary report</atitle><jtitle>Neuroscience letters</jtitle><addtitle>Neurosci Lett</addtitle><date>2016-01-12</date><risdate>2016</risdate><volume>611</volume><spage>59</spage><epage>67</epage><pages>59-67</pages><issn>0304-3940</issn><eissn>1872-7972</eissn><abstract>•It is a longitudinal study of perinatal brain damaged children.•Katona’s neurohabilitation procedure was used as treatment.•89% of preterm ≤34 weeks treated had normal neurodevelopment.•Only 20% of non-treated preterm ≤34 weeks had normal neurodevelopment.•Application of neurohabilitation to perinatal brain damaged infants is recommended. The neurohabilitation treatment has been shown to be a successful method for decreasing the sequelae of perinatal brain damage (PBD) in Hungarian population. The goal of this pilot trial was to introduce this procedure by describing the results of its application in infants with PBD as demonstrated by clinical, developmental and MRI studies. As this procedure has proved to be useful, according the declaration of Helsinki, no control clinical trial was permitted. Infants younger than 2 months of corrected age (CA) with prenatal and/or perinatal risk factors for brain damage. Two groups were considered. One group was treated using the “neurohabilitation” method (n=20), and the other was not treated (n=13) because treatment was voluntarily discontinued after the initial evaluation. Evaluations were carried out prior to 2 months of CA and at 6–8 years of age. All children showed abnormal clinical and MRI characteristics in the first study. The treated group had a higher percentage (90%) of children with normal outcome than did the non-treated group (38%; OR=2.37, CI 95%=1.2–4.7; p&lt;0.005). In this latter group, only one out of five (20%) children born at or before 34 weeks of gestational age had a normal outcome. In contrast, eight out of nine treated preterm infants had normal outcomes (8/9=89%, OR=4.45, CI 95%=0.7–26; p=0.017). This pilot trial confirms previous studies suggesting that Neurohabilitation decreases the neurological and cognitive sequelae of preterm and at-term infants with PBD.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>26598021</pmid><doi>10.1016/j.neulet.2015.11.013</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-6336-4173</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0304-3940
ispartof Neuroscience letters, 2016-01, Vol.611, p.59-67
issn 0304-3940
1872-7972
language eng
recordid cdi_proquest_miscellaneous_1753011724
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Brain - growth & development
Brain - pathology
Brain Diseases - diagnosis
Brain Diseases - pathology
Brain Diseases - physiopathology
Brain Diseases - rehabilitation
Child
Child, Preschool
Female
Humans
Hypoxic ischemic encephalopathy
Infant
Locomotion
Longitudinal Studies
Magnetic Resonance Imaging
Male
MRI
Neurohabilitation
Perinatal brain damage
Pilot Projects
Prenatal risk factors
Preterm encephalopathy
Walking
title Longitudinal study of children with perinatal brain damage in whom early neurohabilitation was applied: Preliminary report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A45%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Longitudinal%20study%20of%20children%20with%20perinatal%20brain%20damage%20in%20whom%20early%20neurohabilitation%20was%20applied:%20Preliminary%20report&rft.jtitle=Neuroscience%20letters&rft.au=Harmony,%20Thal%C3%ADa&rft.date=2016-01-12&rft.volume=611&rft.spage=59&rft.epage=67&rft.pages=59-67&rft.issn=0304-3940&rft.eissn=1872-7972&rft_id=info:doi/10.1016/j.neulet.2015.11.013&rft_dat=%3Cproquest_cross%3E1753011724%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753011724&rft_id=info:pmid/26598021&rft_els_id=S0304394015302500&rfr_iscdi=true